From January 1, 2024 to March 31, 2024, the company has repurchased 915,000 shares, representing 0.46% for CNY 15.39 million. With this, the company has completed the repurchase of 2,020,000 shares, representing 1.02% for CNY 28.79 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.19 CNY | +1.90% | +0.35% | -20.82% |
1st Jan change | Capi. | |
---|---|---|
-20.82% | 469M | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.